BICO Group
BICO Group AB is a company focused on enabling and automating life science laboratories through advanced technologies. The company offers a range of products and services including lab automation projects, instruments, bioinks, tissues, and consumables. BICO also provides services such as service contracts, contract manufacturing, and software solutions. The company's strategy is centered around sustainable profitable growth and automating the life science lab of the future.
Fiscal year 2025 · change from previous year
Development 2021–2025
Business
Share of revenueIncludes automation projects and instruments for labs
Comprises bioinks, tissues, and consumables
Customers
BICO Group serves a diverse range of customers primarily in the life sciences sector. Their customer base includes research institutions, pharmaceutical companies, and biotechnology firms seeking advanced lab automation and bioengineering solutions. These customers are drawn to BICO's innovative products that enhance lab efficiency and enable cutting-edge research. The company's service contracts and custom manufacturing solutions are particularly appealing to organizations looking to optimize their laboratory operations.
Purchase lab automation and bioinks for research purposes
Buy tissues and consumables for drug development
Require consumables and contract manufacturing
Strategy
BICO's strategic priorities include driving sustainable profitable growth and enhancing its product offerings in lab automation and life science solutions. The company aims to achieve double-digit organic growth and improve its EBITDA margin. Strategic divestments, such as the sale of MatTek and Visikol, align with BICO's focus on core competencies. The updated BICO 2.0 strategy emphasizes innovation and operational efficiency to maintain competitive advantage.
To maintain competitive advantage and shareholder value
To lead in life science lab automation solutions
Geography
BICO Group operates globally with a strong presence in the life sciences markets. The company has manufacturing and operational facilities strategically located to serve key markets in Europe and North America. This geographic distribution allows BICO to efficiently meet the demands of its diverse customer base. The company's strategic focus on these regions is driven by the high concentration of research institutions and biotech firms.
Risks
BICO faces several risks including macroeconomic uncertainties, changes in regulatory environments, and operational challenges in lab automation. The company is also exposed to financial risks such as currency fluctuations and interest rate changes. Additionally, the ability to attract and retain skilled employees is crucial for maintaining innovation and operational excellence. The divestment of non-core businesses like MatTek and Visikol helps mitigate some operational risks by allowing BICO to focus on its core strengths.
- Macroeconomic UncertaintiesImpact: HighLikelihood: High
Affect demand for lab automation solutions
- Regulatory ChangesImpact: MediumLikelihood: Medium
Impact product compliance and market access
- Currency FluctuationsImpact: MediumLikelihood: Low
Affect financial performance due to global operations
Accounting
Judgemental itemsReflects compensation for products/services transferred
Impact: Significant on revenue reporting
Adjustments impact reported figures
Impact: Material on financial statements
Similar listed companies
Publicly listed companies with a comparable business focus.
Ginkgo Bioworks Holdings, Inc.
DNA · Biological Products, (No Diagnostic Substances)
Eaco Corp
EACO · Wholesale-Electronic Parts & Equipment, NEC
EACO Corp is a U.S.-based holding company whose operating business is conducted primarily through Bisco Industries and its Canadian subsidiary.
iBio, Inc.
IBIO · Pharmaceutical Preparations
Matinas BioPharma Holdings, Inc.
MTNB · Pharmaceutical Preparations
Quanterix Corp
QTRX · Laboratory Analytical Instruments
Quanterix Corp develops and commercializes ultra-sensitive life science instruments, assay kits, and related services used to measure proteins and biomarkers in biological samples.
Harvard Bioscience, Inc
HBIO · Laboratory Analytical Instruments
Harvard Bioscience designs, manufactures, and sells life-science research tools used in drug discovery, translational medicine, and preclinical testing.
Last updated: 24/09/2026